ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Sanofi Complete list of announcements declared & dividend announcements by Sanofi GCVRZ

Sanofi GCVRZ listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi GCVRZ

Sanofi launches global health brand, to offer 30 meds on non-profit basis
The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business.
Announcement as on 05 July 2022

Sanofi, GSK variant-specific Covid-19 shot found effective against Omicron
"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation," Sanofi said in a statement. Sanofi's Paris-listed shares and GSK's London-listed shares were both up
Announcement as on 24 June 2022

Sanofi, GSK say their next-generation COVID-19 booster has 72% efficacy against omicron
Sanofi and GlaxoSmithKline said Friday that their experimental bivalent COVID-19 booster had a 72% efficacy rate against omicron, and they now plan to submit the data to regulators. The recombinant protein booster protects against the original strain of
Announcement as on 24 June 2022

Sanofi's 'next-generation' COVID-19 booster outperformed traditional boosters
Sanofi said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previously vaccinated with the mRNA shot
Announcement as on 13 June 2022

Regeneron to pay Sanofi up to .1 billion plus royalties for its stake in Libtayo collaboration
Regeneron Pharmaceuticals Inc. announced Thursday an agreement in which it will pay up to .1 billion plus royalties for Sanofi S.A.'s stake in the Regeneron-Sanofi collaboration on cancer treatment Libtayo. Under terms of the deal, Regeneron will make
Announcement as on 02 June 2022

Announcements by Sanofi first page | Next page | Prev page |

GCVRZ Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 0.87
  • 12Day Average: 0.87
  • 20Day Average: 0.87
  • 50Day Average: 0.87
  • 100Day Average: 0.83
  • 150Day Average: 0.73
  • 200Day Average: 0.68

GCVRZ Indicators & signals

Indicator MACD (12,26,9)

0.84, 0.81, 0.05
Indicator MACD is in positive zone

Indicator ADX (14)

0, 28.57, 28.57
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 64
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GCVRZ Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Tue Mar 2020 0.87 0.87 to 0.88 0% 18.75 times
02 Mon Mar 2020 0.87 0.87 to 0.87 0% 0.55 times
28 Fri Feb 2020 0.87 0.87 to 0.88 0% 1.5 times
27 Thu Feb 2020 0.87 0.87 to 0.88 0% 5.49 times
26 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.2 times
25 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.24 times
24 Mon Feb 2020 0.87 0.86 to 0.87 0% 0.57 times
21 Fri Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
20 Thu Feb 2020 0.87 0.87 to 0.87 0% 0.09 times
19 Wed Feb 2020 0.87 0.87 to 0.87 0% 0.28 times
18 Tue Feb 2020 0.87 0.87 to 0.87 0% 0.54 times
17 Mon Feb 2020 0.87 0.87 to 0.87 0% 0 times

Videos related to: GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GCVRZ announcements Sanofi announcements and dividends declared NASDAQ

 

Back to top